| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/2010 | EP2201006A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 06/30/2010 | EP2201005A1 Novel phenoxazin-3-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/30/2010 | EP2201004A1 Novel benzooxazol- and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/30/2010 | EP2201003A1 Process for the preparation of zolmitriptan, salts and solvates thereof |
| 06/30/2010 | EP2201002A1 5-ht7 receptor antagonists |
| 06/30/2010 | EP2201001A1 Novel imidazole derivatives |
| 06/30/2010 | EP2201000A1 Novel imidazole derivatives |
| 06/30/2010 | EP2200998A1 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists |
| 06/30/2010 | EP2200997A1 Synthesis of deuterated catechols and benzoýd¨ý1,3¨dioxoles and derivatives thereof |
| 06/30/2010 | EP2200994A1 Condensed compounds with activity at estrogen receptors |
| 06/30/2010 | EP2200991A1 Antibacterial agents |
| 06/30/2010 | EP2200989A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 06/30/2010 | EP2200987A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 06/30/2010 | EP2200985A1 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 06/30/2010 | EP2200982A1 Piperidine derivatives as nk3 receptor antagonists |
| 06/30/2010 | EP2200980A1 Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention |
| 06/30/2010 | EP2200979A1 Novel derivatives of phenylureas, inhibitors of the soat-1 enzyme, pharmaceutical and cosmetic compositions containing them |
| 06/30/2010 | EP2200977A2 F1f0-atpase inhibitors and related methods |
| 06/30/2010 | EP2200975A1 Dual-acting antihypertensive agents |
| 06/30/2010 | EP2200969A2 Novel compounds active as muscarinic receptor antagonists |
| 06/30/2010 | EP2200968A1 Process for preparing o-desmethylvenlafaxine |
| 06/30/2010 | EP2200967A2 New no-donor aspirin derivatives |
| 06/30/2010 | EP2200962A1 Benzocycloheptene derivatives as estrogens having selective activity |
| 06/30/2010 | EP2200650A2 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 06/30/2010 | EP2200649A2 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 06/30/2010 | EP2200648A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 06/30/2010 | EP2200630A1 Treatment of cardiovascular disorders using the cell differentiation signaling protein nell1 |
| 06/30/2010 | EP2200618A1 Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
| 06/30/2010 | EP2200617A1 Improved brimonidine compositions for treating erythema |
| 06/30/2010 | EP2200616A1 Mipo inhibitors for the treatment of huntington's disease and multiple system atrophy |
| 06/30/2010 | EP2200615A1 A3 adenosine receptor antagonists |
| 06/30/2010 | EP2200614A1 Treatment of vasomotor symptoms |
| 06/30/2010 | EP2200613A2 Phenazine derivatives and uses thereof |
| 06/30/2010 | EP2200612A1 Inhibitors of janus kinases |
| 06/30/2010 | EP2200611A1 Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml) |
| 06/30/2010 | EP2200610A2 Co-administration of pimavanserin with other agents |
| 06/30/2010 | EP2200609A1 Compounds for the treatment of metabolic disorders |
| 06/30/2010 | EP2200608A1 Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of life in lung diseases |
| 06/30/2010 | EP2200607A1 Compounds that modulate intracellular calcium |
| 06/30/2010 | EP2200605A2 Method for stabilizing quercetin |
| 06/30/2010 | EP2200604A1 Methods of increasing sarcosine levels for treating schizophrenia |
| 06/30/2010 | EP2200603A2 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 06/30/2010 | EP2200602A1 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 06/30/2010 | EP2200601A1 Blockers of serotonin and its receptors for the treatment of hepatitis |
| 06/30/2010 | EP2200600A1 1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus |
| 06/30/2010 | EP2200599A1 1-amino-alkylcyclohexane derivatives for the treatment and prevention of hearing loss |
| 06/30/2010 | EP2200598A1 Interval therapy for the treatment of tinnitus |
| 06/30/2010 | EP2200597A2 Method to ameliorate oxidative stress and improve working memory via pterostilbene administration |
| 06/30/2010 | EP2200596A1 Method of treating gaucher disease |
| 06/30/2010 | EP2200595A2 Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 06/30/2010 | EP2200593A1 Abuse resistant drug formulation |
| 06/30/2010 | EP2200591A2 Controlled release pharmaceutical dosage forms of trimetazidine |
| 06/30/2010 | EP2200584A2 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 06/30/2010 | EP2200581A2 Steroid containing ophthalmic drug delivery systems |
| 06/30/2010 | EP2200579A2 Antiviral topical formulations in the form of a bio-adhesive gel |
| 06/30/2010 | EP2200573A2 Resveratrol ferulate compounds, compositions containing the compounds, and methods of using the same |
| 06/30/2010 | EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds |
| 06/30/2010 | EP2200437A1 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| 06/30/2010 | EP2200436A1 Substituted pyrimidinyl-amines as protein kinase inhibitors |
| 06/30/2010 | EP2200431A1 Novel compositions and methods for cancer treatment |
| 06/30/2010 | EP2089381B1 Indoles which act as via receptor antagonists |
| 06/30/2010 | EP2066674B1 Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents |
| 06/30/2010 | EP2021336B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/30/2010 | EP1943216B1 Prolinamide derivatives as sodium channel modulators |
| 06/30/2010 | EP1899307B1 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands |
| 06/30/2010 | EP1891008B1 Oxindoles as kinase inhibitors |
| 06/30/2010 | EP1841763B1 5-heteroaryl thiazoles and their use as pi3k inhibitors |
| 06/30/2010 | EP1841757B1 Heteroaromatic quinoline compounds and their use as pde10 inhibitors |
| 06/30/2010 | EP1838308B1 [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 06/30/2010 | EP1827423B1 Novel cyclic ureas used as inhibitors of metalloproteases |
| 06/30/2010 | EP1797034B1 Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 06/30/2010 | EP1735270B1 Diamino alcohols and their use as renin inhibitors |
| 06/30/2010 | EP1682552B1 Tocopherol-modified therapeutic drug compounds |
| 06/30/2010 | EP1673349B1 Benzimidazole derivatives: preparation and pharmaceutical applications |
| 06/30/2010 | EP1618107B1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists |
| 06/30/2010 | EP1599480B1 Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 06/30/2010 | EP1575589B1 Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/30/2010 | EP1545548B1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 06/30/2010 | EP1542970B1 Pyrrolidone derivatives as maob inhibitors |
| 06/30/2010 | EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction |
| 06/30/2010 | EP1494686B1 Oral rehydration composition |
| 06/30/2010 | EP1476435B1 Novel pyridin- and pyrimidin-derivatives |
| 06/30/2010 | EP1465616B1 Treatment of statin side effects using uridine derivatives |
| 06/30/2010 | EP1411927B1 Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 06/30/2010 | EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors |
| 06/30/2010 | EP1366760B1 Tablets quickly disintegrated in oral cavity |
| 06/30/2010 | EP1366044B1 8-{4-[3-(5-fluoro-1h-indol-3-yl)propyl ]-1-piperazinyl} -2-methyl-2h-1, 4-benzoxazin-3(4h)-one methanesulfonate with high affinity for the dopamine d2 receptor and the serotonin reuptake site |
| 06/30/2010 | EP1330436B1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists |
| 06/30/2010 | EP1291016B1 New use of modafinil and the d/l enantiomer |
| 06/30/2010 | EP1284727B1 Intracorporeal medicaments for photodynamic treatment of disease |
| 06/30/2010 | EP1278735B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 06/30/2010 | CN201515889U Pillow for neck |
| 06/30/2010 | CN201515888U A dual purpose pillow for neck portion and waist portion |
| 06/30/2010 | CN201515743U Sterilization sweat absorbing massage magnetic treatment insole |
| 06/30/2010 | CN1895259B Preparation of injection for treating cardiovascular disease |
| 06/30/2010 | CN1829743B Complex matrix for biomedical use |
| 06/30/2010 | CN1796402B Technique for preparing general alkaloid of Hubei fritillary bulb |
| 06/30/2010 | CN1781479B Chinese small iris seed agent dispersion system and its preparing method |
| 06/30/2010 | CN1533276B Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 06/30/2010 | CN101765602A 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |